# Infection Prophylaxis in Total Joint Replacement

> **NCT06126614** · PHASE3 · RECRUITING · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 21006 (estimated)

## Conditions studied

- Periprosthetic Joint Infection

## Interventions

- **DRUG:** Chlorhexidine Gluconate
- **DRUG:** Vancomycin Hydrochloride
- **OTHER:** Povidone-Iodine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT06126614
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 21006 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126614, "Infection Prophylaxis in Total Joint Replacement". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06126614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*